Pharmanutra S.p.A. (BIT:PHN)
Italy · Delayed Price · Currency is EUR 82.50
+0.50 (0.61%)
Jul 28, 2026, 11:02 AM CET
Pharmanutra Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 21.02 | 20 | 16.61 | 12.83 | 15.05 | 13.77 |
Depreciation & Amortization | 3.99 | 3.9 | 3.93 | 3.12 | 1.32 | 1.39 |
Other Adjustments | 0.22 | 0.28 | 1.04 | 0.69 | 0.74 | 0.41 |
Change in Receivables | -4.72 | -2.87 | -2.98 | 2.22 | -5.15 | -1.77 |
Changes in Inventories | -0.05 | -1.91 | 1.22 | -2.91 | -2.4 | -0.97 |
Changes in Accounts Payable | 0.74 | 4.1 | 1.43 | -0.78 | 7.14 | 2.58 |
Changes in Accrued Expenses | 0.53 | 0.49 | 0.59 | -2.31 | 0.57 | 0.47 |
Changes in Income Taxes Payable | -0.51 | -1.3 | 0.02 | 2.55 | -3.04 | 3.59 |
Changes in Other Operating Activities | -3.7 | -3.38 | -0.06 | -5.35 | 2.2 | 0.31 |
Operating Cash Flow | 19.45 | 19.56 | 20.42 | 12.09 | 17.47 | 20.41 |
Operating Cash Flow Growth | -21.49% | -4.22% | 68.91% | -30.77% | -14.44% | 73.02% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -3.43 | -3.13 | -4.25 | -13.25 | -26.16 | -4.99 |
Sale of Property, Plant & Equipment | 0.08 | 0.02 | 0.66 | 0.55 | 0.27 | 0.08 |
Purchases of Investments | -0.13 | - | - | -1.55 | -0.34 | -0.2 |
Proceeds from Sale of Investments | -0.83 | 2.01 | 0.1 | 0.11 | - | - |
Other Investing Activities | - | -0.56 | -7.39 | - | 0.29 | 0.02 |
Investing Cash Flow | -5.27 | -3.36 | -2.21 | -14.7 | -26.72 | -5.54 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 1.6 | 2.39 | 0.01 | 9.78 | 15.19 | 5.09 |
Long-Term Debt Repaid | -3.86 | -5.94 | -5.56 | -0.35 | -3.78 | -0.72 |
Net Long-Term Debt Issued (Repaid) | -2.27 | -3.55 | -5.55 | 9.43 | 11.41 | 4.37 |
Repurchase of Common Stock | -1.08 | -1.33 | -0.55 | -1.65 | -2.36 | 0 |
Net Common Stock Issued (Repurchased) | -1.08 | -1.33 | -0.55 | -1.65 | -2.36 | 0 |
Common Dividends Paid | -9.59 | -9.59 | -8.17 | -7.71 | -6.85 | -6.49 |
Other Financing Activities | -0.4 | -0.09 | -0.03 | 0.86 | -0.04 | 0.38 |
Financing Cash Flow | -16.85 | -13.12 | -21.6 | -0.52 | 1.89 | -1.92 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -5.26 | 3.08 | -3.39 | -3.13 | -7.36 | 12.95 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 16.02 | 16.43 | 16.17 | -1.16 | -8.69 | 15.43 |
Free Cash Flow Growth | -22.24% | 1.59% | - | - | - | 52.49% |
FCF Margin | 15.66% | 12.06% | 13.67% | -1.14% | -10.42% | 22.41% |
Free Cash Flow Per Share | 1.68 | 1.71 | 1.68 | -0.12 | -0.90 | 1.59 |
Levered Free Cash Flow | 16.32 | 15.22 | 13.94 | 3.35 | 6.09 | 20.52 |
Unlevered Free Cash Flow | 20.4 | 18.76 | 19.57 | -6.02 | -5.57 | 16.06 |